<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The entity 'B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, unclassifiable, with features intermediate between diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>)' refers to B cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> that share overlapping characteristics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A subset of these 'grey-zone <z:hpo ids='HP_0002665'>lymphomas</z:hpo>' possesses C-MYC and IGH translocations but, in addition, contains additional rearrangements of BCL2 and/or BCL6 genes </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate if the proliferation fraction by Ki67 immunostaining can be used to identify such double-/triple-hit <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: We studied 492 cases of mature aggressive B cell <z:hpo ids='HP_0011792'>neoplasms by histology</z:hpo>, immunohistochemistry and interphase fluorescence in-situ hybridization (FISH) using break-apart probes against C-MYC, BCL2, BCL6, IGH, MALT1, PAX5 and CCND1 </plain></SENT>
<SENT sid="4" pm="."><plain>Forty Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 28 cases of MYC(+) double-/triple-hit <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were identified </plain></SENT>
<SENT sid="5" pm="."><plain>Of the latter, 77% and 54% displayed proliferation fractions exceeding 75% and 90%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>With a cut-off of &gt;75% by Ki67 immunostaining, the sensitivity and specificity for detection of MYC(+) double/triple translocations was 0.77 and 0.36 </plain></SENT>
<SENT sid="7" pm="."><plain>Raising the proliferation fraction criterion to &gt;90% improved the specificity to 0.62 at the expense of a low sensitivity of 0.54 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Immunostaining for Ki67 is not a useful approach to prescreen B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> for MYC(+) double/triple translocations </plain></SENT>
</text></document>